GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » PB Ratio

Zenotech Laboratories (BOM:532039) PB Ratio : 4.16 (As of Jun. 16, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-16), Zenotech Laboratories's share price is ₹61.69. Zenotech Laboratories's Book Value per Share for the quarter that ended in Mar. 2024 was ₹14.84. Hence, Zenotech Laboratories's PB Ratio of today is 4.16.

Good Sign:

Zenotech Laboratories Ltd stock PB Ratio (=4.16) is close to 1-year low of 3.99

The historical rank and industry rank for Zenotech Laboratories's PB Ratio or its related term are showing as below:

BOM:532039' s PB Ratio Range Over the Past 10 Years
Min: 1.99   Med: 4.7   Max: 36.12
Current: 4.16

During the past 13 years, Zenotech Laboratories's highest PB Ratio was 36.12. The lowest was 1.99. And the median was 4.70.

BOM:532039's PB Ratio is ranked worse than
79.87% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.91 vs BOM:532039: 4.16

During the past 12 months, Zenotech Laboratories's average Book Value Per Share Growth Rate was 10.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 23.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Zenotech Laboratories was 23.20% per year. The lowest was -62.60% per year. And the median was 11.55% per year.

Back to Basics: PB Ratio


Zenotech Laboratories PB Ratio Historical Data

The historical data trend for Zenotech Laboratories's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories PB Ratio Chart

Zenotech Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 4.41 4.35 3.49 3.98

Zenotech Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.49 - 3.91 - 3.98

Competitive Comparison of Zenotech Laboratories's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's PB Ratio falls into.



Zenotech Laboratories PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Zenotech Laboratories's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=61.69/14.835
=4.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Zenotech Laboratories  (BOM:532039) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Zenotech Laboratories PB Ratio Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories (BOM:532039) Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines